I. Persson

4.5k total citations
51 papers, 2.8k citations indexed

About

I. Persson is a scholar working on Genetics, Oncology and Pharmacology. According to data from OpenAlex, I. Persson has authored 51 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 12 papers in Oncology and 9 papers in Pharmacology. Recurrent topics in I. Persson's work include Estrogen and related hormone effects (14 papers), Cancer Risks and Factors (9 papers) and Endometrial and Cervical Cancer Treatments (8 papers). I. Persson is often cited by papers focused on Estrogen and related hormone effects (14 papers), Cancer Risks and Factors (9 papers) and Endometrial and Cervical Cancer Treatments (8 papers). I. Persson collaborates with scholars based in Sweden, United States and United Kingdom. I. Persson's co-authors include Magnus Ingelman‐Sundberg, R. Bergström, Sver­ker Ljunghall, Hans‐Olov Adami, Pär Sparén, A. Melin, Agneta Bergqvist, Leif Bergkvist, Inger Johansson and Lars Holmberg and has published in prestigious journals such as Journal of Clinical Oncology, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

I. Persson

49 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. Persson Sweden 26 822 687 618 516 382 51 2.8k
Karen L. Koenig United States 33 846 1.0× 1.0k 1.5× 715 1.2× 861 1.7× 425 1.1× 71 3.4k
Bernard Candas Canada 31 995 1.2× 510 0.7× 1.8k 3.0× 649 1.3× 413 1.1× 74 4.2k
Léonello Cusan Canada 30 859 1.0× 286 0.4× 1.7k 2.8× 475 0.9× 593 1.6× 42 3.2k
Peter Eggena United States 30 703 0.9× 146 0.2× 1.4k 2.3× 668 1.3× 239 0.6× 116 3.1k
José‐Luis Gomez Canada 24 621 0.8× 367 0.5× 1.4k 2.3× 393 0.8× 453 1.2× 27 2.9k
Jian Shen China 34 383 0.5× 351 0.5× 334 0.5× 1.3k 2.6× 83 0.2× 145 3.5k
J. Pryse‐Davies United Kingdom 29 839 1.0× 176 0.3× 758 1.2× 234 0.5× 471 1.2× 83 2.7k
Sabina Rinaldi France 40 842 1.0× 1.7k 2.4× 1.6k 2.6× 1.6k 3.2× 356 0.9× 116 4.7k
R.D. Bulbrook United Kingdom 32 1.2k 1.5× 1.2k 1.7× 911 1.5× 462 0.9× 307 0.8× 137 3.4k
J. A. Franklyn United Kingdom 41 885 1.1× 288 0.4× 4.1k 6.6× 967 1.9× 219 0.6× 118 5.5k

Countries citing papers authored by I. Persson

Since Specialization
Citations

This map shows the geographic impact of I. Persson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Persson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Persson more than expected).

Fields of papers citing papers by I. Persson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Persson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Persson. The network helps show where I. Persson may publish in the future.

Co-authorship network of co-authors of I. Persson

This figure shows the co-authorship network connecting the top 25 collaborators of I. Persson. A scholar is included among the top collaborators of I. Persson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Persson. I. Persson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Staa, Tjeerd van, Liam Smeeth, I. Persson, John Parkinson, & Hubert G. M. Leufkens. (2008). Evaluating drug toxicity signals: is a hierarchical classification of evidence useful or a hindrance?. Pharmacoepidemiology and Drug Safety. 17(5). 475–484. 4 indexed citations
2.
Staa, Tjeerd van, Liam Smeeth, I. Persson, John Parkinson, & H.G.M. Leufkens. (2008). What is the harm-benefit ratio of Cox-2 inhibitors?. International Journal of Epidemiology. 37(2). 405–413. 25 indexed citations
3.
Melin, A., Pär Sparén, I. Persson, & Agneta Bergqvist. (2006). Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Human Reproduction. 21(5). 1237–1242. 228 indexed citations
4.
Weiderpass, Elisabete, I. Persson, Håkan Melhus, et al.. (2000). Estrogen receptor   gene polymorphisms and endometrial cancer risk. Carcinogenesis. 21(4). 623–627. 90 indexed citations
5.
Persson, I., et al.. (1999). Genetic polymorphism of xenobiotic metabolizing enzymes among Chinese lung cancer patients. International Journal of Cancer. 81(3). 325–329. 86 indexed citations
6.
Michaëlsson, Karl, John A. Baron, Olof Johnell, I. Persson, & Sver­ker Ljunghall. (1998). Variation in the Efficacy of Hormone Replacement Therapy in the Prevention of Hip Fracture. Osteoporosis International. 8(6). 540–546. 36 indexed citations
7.
Persson, I., Erik Thurfjell, & Lars Holmberg. (1997). Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density.. Journal of Clinical Oncology. 15(10). 3201–3207. 152 indexed citations
8.
Masimirembwa, Collen, I. Persson, Leif Bertilsson, Julia A. Hasler, & Magnus Ingelman‐Sundberg. (1996). A novel mutant variant of the CYP2D6 gene (CYP2D617) common in a black African population: association with diminished debrisoquine hydroxylase activity. British Journal of Clinical Pharmacology. 42(6). 713–719. 153 indexed citations
9.
Agrell, Johan, et al.. (1995). Delayed density-dependence in a small-rodent population. Proceedings of the Royal Society B Biological Sciences. 262(1363). 65–70. 47 indexed citations
10.
Adami, Hans‐Olov, I. Persson, Anders Ekbom, et al.. (1995). The aetiology and pathogenesis of human breast cancer. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 333(1-2). 29–35. 43 indexed citations
11.
Mallmin, Hans, Sver­ker Ljunghall, I. Persson, & R. Bergström. (1994). Risk factors for fractures of the distal forearm: A population-based case-control study. Osteoporosis International. 4(6). 298–304. 101 indexed citations
12.
Persson, I., Marja­‐Liisa Dahl, Janeric Seidegård, et al.. (1993). Genetic polymorphism of cytochrome P4502E1 in a Swedish population. FEBS Letters. 319(3). 207–211. 165 indexed citations
13.
Larsson, Karin, Sver­ker Ljunghall, Ulla Brith Krusemo, et al.. (1993). The risk of hip fractures in patients with primary hyperparathyroidism: a population‐based cohort study with a follow‐up of 19 years. Journal of Internal Medicine. 234(6). 585–593. 85 indexed citations
14.
Ingelman‐Sundberg, Magnus, et al.. (1992). Genetic polymorphism of cytochromes P450: Interethnic differences and relationship to incidence of lung cancer. Pharmacogenetics. 2(6). 264–271. 33 indexed citations
15.
Naessén, Tord, I. Persson, Sver­ker Ljunghall, & R. Bergström. (1992). Women with climacteric symptoms: A target group for prevention of rapid bone loss and osteoporosis. Osteoporosis International. 2(5). 225–231. 54 indexed citations
16.
Persson, I., Hans‐Olov Adami, Leif Bergkvist, et al.. (1989). Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study.. PubMed Central. 298(6667). 147–151. 312 indexed citations
17.
Alle­beck, Peter, H‐O Adami, Lars Klareskog, & I. Persson. (1989). Non-Contraceptive Hormones and Rheumatoid Arthritis: Possibilities of Using a Swedish Population-Based Cohort. Lara D. Veeken. XXVIII(suppl 1). 38–40. 1 indexed citations
18.
Bergkvist, Leif, et al.. (1988). Risk Factors for Breast and Endometrial Cancer in a Cohort of Women Treated with Menopausal Oestrogens. International Journal of Epidemiology. 17(4). 732–737. 21 indexed citations
19.
Persson, I., et al.. (1984). Evaluation of sanguinarine chloride in control of plaque in the dental practice.. PubMed. Suppl 5. S90–3. 10 indexed citations
20.
Persson, I., et al.. (1970). A Survey of 9 Gm-Factors, the Inv and the ISf Systems in Danes. Human Heredity. 20(3). 275–280. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karen L. Koenig Breakdown of academic impact, for papers by Bernard Candas Breakdown of academic impact, for papers by Léonello Cusan Breakdown of academic impact, for papers by Peter Eggena Breakdown of academic impact, for papers by José‐Luis Gomez Breakdown of academic impact, for papers by Jian Shen Breakdown of academic impact, for papers by J. Pryse‐Davies Breakdown of academic impact, for papers by Sabina Rinaldi Breakdown of academic impact, for papers by R.D. Bulbrook Breakdown of academic impact, for papers by J. A. Franklyn
Rankless by CCL
2026